Malondialdehyde-acetaldehyde adduct is the dominant epitope after MDA modification of proteins in atherosclerosis
about
The innate immune response to products of phospholipid peroxidationRecognition of malondialdehyde-modified proteins by the C terminus of complement factor H is mediated via the polyanion binding site and impaired by mutations found in atypical hemolytic uremic syndrome.Malondialdehyde-acetaldehyde adducts and anti-malondialdehyde-acetaldehyde antibodies in rheumatoid arthritis.Unique antibody responses to malondialdehyde-acetaldehyde (MAA)-protein adducts predict coronary artery diseaseAtheroprotective immunization with malondialdehyde-modified LDL is hapten specific and dependent on advanced MDA adducts: implications for development of an atheroprotective vaccineIGHV1-69-encoded antibodies expressed in chronic lymphocytic leukemia react with malondialdehyde-acetaldehyde adduct, an immunodominant oxidation-specific epitopeNatural antibodies of newborns recognize oxidative stress-related malondialdehyde acetaldehyde adducts on apoptotic cells and atherosclerotic plaques.Oxidative and reductive metabolism of lipid-peroxidation derived carbonyls.Peptide mimotopes of malondialdehyde epitopes for clinical applications in cardiovascular disease.Oxidative stress, innate immunity, and age-related macular degenerationHuman IgM Antibodies to Malondialdehyde Conjugated With Albumin Are Negatively Associated With Cardiovascular Disease Among 60-Year-Olds.Malondialdehyde mediates oxidized LDL-induced coronary toxicity through the Akt-FGF2 pathway via DNA methylation.Protein lipid modifications--More than just a greasy ballast.Direct antioxidant properties of methotrexate: Inhibition of malondialdehyde-acetaldehyde-protein adduct formation and superoxide scavengingNon-invasive ventilation improves hemorheology status in hypoxemic patients with acute myocardial infarction after PCI.Malondialdehyde epitopes are sterile mediators of hepatic inflammation in hypercholesterolemic mice.An effective strategy for the synthesis of biocompatible gold nanoparticles using danshensu antioxidant: prevention of cytotoxicity via attenuation of free radical formation.Plasma IgA antibody levels to malondialdehyde acetaldehyde-adducts are associated with inflammatory mediators, obesity and type 2 diabetes.mir-193 targets ALDH2 and contributes to toxic aldehyde accumulation and tyrosine hydroxylase dysfunction in cerebral ischemia/reperfusion injury.Scavenger Receptor A Mediates the Clearance and Immunological Screening of MDA-Modified Antigen by M2-Type Macrophages.Immunization with gingipain A hemagglutinin domain of Porphyromonas gingivalis induces IgM antibodies binding to malondialdehyde-acetaldehyde modified low-density lipoprotein.PET/MR Imaging of Malondialdehyde-Acetaldehyde Epitopes With a Human Antibody Detects Clinically Relevant Atherothrombosis.Immunoproteomic identification of biotransformed self-proteins from the livers of female Balb/c mice following chronic ethanol administration.
P2860
Q28389385-ADF3E7CE-6CA3-4C80-8065-DB8BB0B12D8BQ33412152-5D9E8E3D-7064-4C1A-9D2E-2B780CE960E1Q33793383-0D4DDB68-00DC-4B00-A06C-F98187706DCBQ34166358-88310E8B-0995-4DB4-B198-5BC1320C57FFQ34238712-6003968F-58E8-4EB7-AF06-7EFA32068B5BQ34804388-C9CF0955-78BD-40AD-A1CF-0CF9E87E23E4Q34881734-60F596B7-94B1-4216-B769-9DB142B36343Q35554080-7F61A9DA-BD60-4CD9-BFE7-7BCE44B939E7Q36020265-2DB31F3D-CD25-43BE-A284-6C49FB6C20B2Q36940296-7E79FF81-5CF3-4D96-8E7B-089529220754Q37556461-3DEFF809-E54D-4142-A190-F109FD171E00Q37596872-C5BC0DA4-2F24-44B9-A39C-EC265BEDFCFFQ38673481-A5E83C0F-93FD-4E80-A0E4-1486EED34457Q38695031-FD64839D-99A6-476A-9697-9E849DA42B44Q38701343-9C26D309-BBAF-430A-905D-3197771F3ADAQ39096019-78ED4436-6641-4BE2-9CEA-CDF70B9661D5Q39400277-3C81E2C3-A2C0-4257-A2B1-DC6238EB5DB9Q43523503-22BB030B-8C89-49D4-8B8F-2787513868FDQ47094072-A8A1AF07-4074-41A4-8A18-48461D0FB4E7Q47152812-4062BF3F-FA57-46C8-8657-EAEAD07C37E1Q48252650-19512668-0154-47F6-8826-F2E55CE08C00Q49955253-7261AC2B-7C28-4AC5-B451-A588F558E7CBQ51337833-1E1E37EE-82F7-4130-BFC9-BBA6BA36736C
P2860
Malondialdehyde-acetaldehyde adduct is the dominant epitope after MDA modification of proteins in atherosclerosis
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Malondialdehyde-acetaldehyde a ...... of proteins in atherosclerosis
@ast
Malondialdehyde-acetaldehyde a ...... of proteins in atherosclerosis
@en
Malondialdehyde-acetaldehyde a ...... of proteins in atherosclerosis
@nl
type
label
Malondialdehyde-acetaldehyde a ...... of proteins in atherosclerosis
@ast
Malondialdehyde-acetaldehyde a ...... of proteins in atherosclerosis
@en
Malondialdehyde-acetaldehyde a ...... of proteins in atherosclerosis
@nl
prefLabel
Malondialdehyde-acetaldehyde a ...... of proteins in atherosclerosis
@ast
Malondialdehyde-acetaldehyde a ...... of proteins in atherosclerosis
@en
Malondialdehyde-acetaldehyde a ...... of proteins in atherosclerosis
@nl
P2093
P2860
P1476
Malondialdehyde-acetaldehyde a ...... of proteins in atherosclerosis
@en
P2093
Carlos D Hunter
Courtney S Schaffert
Daniel R Anderson
Dean J Tuma
Lynell W Klassen
Michael J Duryee
Robert P Garvin
P2860
P304
P356
10.1016/J.FREERADBIOMED.2010.08.001
P577
2010-08-06T00:00:00Z